In the development of breast cancer, tumor cells obtain resistance to TGF-β-mediated growth arrest, it has been reported that TGF-β pathway retains the ability to promote the processes that support tumor progression such as tumor cell epithelial-to-mesenchymal transition, invasion, dissemination, and immune evasion [27–29]. This evidence concerns the gene TGFB1 and neoplasm.